End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
82.2 TWD | +1.99% | +10.34% | +19.65% |
03-15 | Johnson Health Tech .Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
03-05 | BowFlex files for bankruptcy with $37.5 million buyout offer | RE |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
Strengths
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The company has insufficient levels of profitability.
- The company benefits from high valuations in earnings multiples.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Sector: Recreational Products
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+19.65% | 763M | - | ||
+5.73% | 4.04B | B+ | ||
-1.49% | 3.94B | B- | ||
+10.53% | 2.92B | B+ | ||
-1.16% | 1.9B | B+ | ||
+92.11% | 1.23B | - | ||
-48.11% | 1.16B | D | ||
-9.30% | 853M | B- | ||
-4.80% | 838M | B | ||
+2.24% | 809M | - | C |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 1736 Stock
- Ratings Johnson Health Tech .Co., Ltd.